Clinical trial · people
MK-677: moderate GH isoform shifts over 8 weeks in obese men
Checked against the paper Clinical trialPublished by PepVault
The takeaway
The authors judged these moderate shifts in GH forms likely of small importance for how people respond to MK-677.
- Kind
- Clinical trial
- Studied in
- People
- Number studied
- 12
- Published
- 2003
- Journal
- Growth Horm IGF Res
What they tested
The team tested whether the mix of growth hormone (GH) forms in the blood changes over 8 weeks of daily oral MK-677.
How the study was done
A clinical trial in which 12 obese men took MK-677 25mg by mouth daily for 8 weeks. GH forms were measured after the first dose and again at 2 and 8 weeks.

What they found
GH circulates in several forms, called isoforms. In peak GH samples, the share of non-22K isoforms (forms other than the 22kDa one) was higher after the first MK-677 dose than at 2 weeks (p<0.01) and 8 weeks (p<0.05). In samples taken away from the GH peak after the first dose, that share was similar to the peak samples at 2 and 8 weeks. The share of the 20K form in 2-hour samples was lower after the first dose than at 2 weeks (p<0.01) and 8 weeks (p<0.05).
What it doesn’t show
This was a small group of 12 obese men followed for 8 weeks, so it doesn't show what happens in women, people without obesity, or over longer use. The comparisons are between time points in the same treated men.
The paper
Svensson et al. The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms. Growth Horm IGF Res. 2003.
The compound
More studies on MK-677
- MK-677 raised IGF-1 but not most function after hip fractureRandomized trial · people · 2011
- MK-677: fat-free mass rose 1.1 kg vs -0.5 kg on placebo at 1 yearRandomized trial · people · 2008
- MK-677 plus alendronate: 4.2% femoral neck BMD gain vs 2.5% aloneRandomized trial · people · 2001
- MK-677 raised bone turnover markers in adults 65 and olderRandomized trial · people · 1999
- MK-677 reversed diet-driven nitrogen loss in 8 healthy adultsRandomized trial · people · 1998
- MK-677: IGF-I rose 52% at 10 mg and 79% at 50 mg in GH-deficient menRandomized trial · people · 1997
- Every study on MK-677
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.